ArticleHuman mutation2026
TMEM106C, BSG, COPE, CDCA8, KPNA2, LIG1, UQCRH, and CCT5: Predictive of Survival and Immunotherapy Resistance in Hepatocellular Carcinoma.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with cellular senescence playing a context-dependent role in tumor progression and the immunosuppressive microenvironment. This study is aimed at identifying senescence-related gene signatures through integrated single-cell and transcriptomic analyses to construct a robust prognostic model for predicting survival and immunotherapy response in HCC patients. Methods: We obtained single-cell RNA sequencing (scRNA-seq) data from the Gene Expression Omnibus (GEO) database and transcriptomic data from The Cancer Genome Atlas (TCGA). The scRNA-seq data were processed using the Seurat and Harmony packages for cell clustering and batch correction. Senescence scores were calculated via the AUCell package, and differentially expressed genes were identified using the limma package. Prognostic genes were selected through univariate and LASSO Cox regression (glmnet package) to construct a risk model, which was validated in multiple independent cohorts. Immune infiltration was assessed with single-sample gene set enrichment analysis (ssGSEA), TIMER, and MCPCounter algorithms, and response to immune checkpoint blockade was predicted using the tumor immune dysfunction and exclusion (TIDE) platform. Experimental validation included qRT-PCR, Cell Counting Kit-8 (CCK-8), wound healing, and Transwell assays in HCC cell lines. Results: A total of 80,997 identified cells were allocated to eight clusters, with an evidently higher percentage of natural killer (NK) cells in HCC samples. A higher senescence score was also seen in HCC samples, and poor prognosis was noticed in the patients of high senescence score group. Further, the DEGs were intersected with the genes highly expressed in Population 4 of NK cells to reveal their enrichment in cell cycle and cell division. Further, eight genes ( Discussion: This integrated analysis establishes a senescence-related gene signature as a robust tool for prognostic stratification and immunotherapy response prediction in HCC. The model highlights the complex interplay between cellular senescence and the immunosuppressive tumor microenvironment, offering insights for personalized treatment strategies. Furthermore, the identified biomarker Conclusion: These discoveries provide novel evidence on senescence in HCC, which may tailor the pharmacological interventions to improve the clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.